170 related articles for article (PubMed ID: 16505120)
1. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.
Li PK; Pandit B; Sackett DL; Hu Z; Zink J; Zhi J; Freeman D; Robey RW; Werbovetz K; Lewis A; Li C
Mol Cancer Ther; 2006 Feb; 5(2):450-6. PubMed ID: 16505120
[TBL] [Abstract][Full Text] [Related]
2. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide.
Iguchi T; Yachide-Noguchi T; Hashimoto Y; Nakazato S; Sagawa M; Ikeda Y; Kizaki M
Int J Mol Med; 2008 Feb; 21(2):163-8. PubMed ID: 18204782
[TBL] [Abstract][Full Text] [Related]
3. Benzopyridooxathiazepine derivatives as novel potent antimitotic agents.
Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Berthelot P; Lebegue N
Bioorg Med Chem; 2009 Feb; 17(3):1132-8. PubMed ID: 19162484
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.
Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Tan UK; Yeh TK; Kuo CC; Chang YW; Lu PH; Tung YS; Lin KT; Chang JY; Hsieh HP
ChemMedChem; 2006 Oct; 1(10):1106-18. PubMed ID: 16952120
[TBL] [Abstract][Full Text] [Related]
5. A facile synthesis of diaryl pyrroles led to the discovery of potent colchicine site antimitotic agents.
Romagnoli R; Oliva P; Salvador MK; Manfredini S; Padroni C; Brancale A; Ferla S; Hamel E; Ronca R; Maccarinelli F; Rruga F; Mariotto E; Viola G; Bortolozzi R
Eur J Med Chem; 2021 Mar; 214():113229. PubMed ID: 33550186
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 1-methyl-2-(3',4',5'-trimethoxybenzoyl)-3-aminoindoles as a new class of antimitotic agents and tubulin inhibitors.
Romagnoli R; Baraldi PG; Sarkar T; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Hsieh HP; Hamel E
J Med Chem; 2008 Mar; 51(5):1464-8. PubMed ID: 18260616
[TBL] [Abstract][Full Text] [Related]
7. Tubulin-polymerization inhibitors derived from thalidomide.
Inatsuki S; Noguchi T; Miyachi H; Oda S; Iguchi T; Kizaki M; Hashimoto Y; Kobayashi H
Bioorg Med Chem Lett; 2005 Jan; 15(2):321-5. PubMed ID: 15603947
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization.
Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E
J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607
[TBL] [Abstract][Full Text] [Related]
9. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
[TBL] [Abstract][Full Text] [Related]
10. Novel benzopyridothiadiazepines as potential active antitumor agents.
Lebegue N; Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Chavatte P; Berthelot P
J Med Chem; 2005 Nov; 48(23):7363-73. PubMed ID: 16279796
[TBL] [Abstract][Full Text] [Related]
11. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles.
Romagnoli R; Baraldi PG; Salvador MK; Prencipe F; Bertolasi V; Cancellieri M; Brancale A; Hamel E; Castagliuolo I; Consolaro F; Porcù E; Basso G; Viola G
J Med Chem; 2014 Aug; 57(15):6795-808. PubMed ID: 25025853
[TBL] [Abstract][Full Text] [Related]
13. Phenylcinnamides as novel antimitotic agents.
Leslie BJ; Holaday CR; Nguyen T; Hergenrother PJ
J Med Chem; 2010 May; 53(10):3964-72. PubMed ID: 20411988
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies of thalidomide analogs with a taxol-like mode of action.
Pandit B; Hu Z; Chettiar SN; Zink J; Xiao Z; Etter JP; Bhasin D; Li PK
Bioorg Med Chem Lett; 2013 Dec; 23(24):6902-4. PubMed ID: 24169233
[TBL] [Abstract][Full Text] [Related]
15. Concise syntheses of 7-anilino-indoline-N-benzenesulfonamides as antimitotic and vascular disrupting agents.
Mehndiratta S; Chiang YF; Lai MJ; Lee HY; Chen MC; Kuo CC; Chang CY; Chang JY; Liou JP
Bioorg Med Chem; 2014 Sep; 22(17):4917-23. PubMed ID: 25059503
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activities of (R)- and (S)-N-(4-Methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-aminium chloride as potent cytotoxic antitubulin agents.
Gangjee A; Zhao Y; Hamel E; Westbrook C; Mooberry SL
J Med Chem; 2011 Sep; 54(17):6151-5. PubMed ID: 21786793
[TBL] [Abstract][Full Text] [Related]
17. Modification of the phenyl ring B of phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates by pyridinyl moiety leads to novel antimitotics targeting the colchicine-binding site.
Ouellette V; Bouzriba C; Chavez Alvarez AC; Hamel-Côté G; Fortin S
Bioorg Med Chem Lett; 2024 Jun; 105():129745. PubMed ID: 38614151
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability.
La Regina G; Bai R; Rensen W; Coluccia A; Piscitelli F; Gatti V; Bolognesi A; Lavecchia A; Granata I; Porta A; Maresca B; Soriani A; Iannitto ML; Mariani M; Santoni A; Brancale A; Ferlini C; Dondio G; Varasi M; Mercurio C; Hamel E; Lavia P; Novellino E; Silvestri R
J Med Chem; 2011 Dec; 54(24):8394-406. PubMed ID: 22044164
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis of phenstatin/isocombretastatin-oxindole conjugates as antimitotic agents.
Kumar GB; Nayak VL; Sayeed IB; Reddy VS; Shaik AB; Mahesh R; Baig MF; Shareef MA; Ravikumar A; Kamal A
Bioorg Med Chem; 2016 Apr; 24(8):1729-40. PubMed ID: 26970659
[TBL] [Abstract][Full Text] [Related]
20. Pyrimido[4,5-c]quinolin-1(2H)-ones as a novel class of antimitotic agents: Synthesis and in vitro cytotoxic activity.
Metwally K; Pratsinis H; Kletsas D
Eur J Med Chem; 2007 Mar; 42(3):344-50. PubMed ID: 17141923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]